Tag: ASX:CYP
December 13, 2018
NHMRC to Fund Major Phase 2 Clinical Trial of Cynata’s Cymerus MSCs in Patients with Osteoarthritis
Cynata Therapeutics (ASX:CYP), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that the Australian National Health... September 19, 2018
Cynata’s Cymerus MSCs Ameliorate Cytokine Release Syndrome in Preclinical Study
Australian stem cell and regenerative medicine company Cynata Therapeutics (ASX:CYP) is pleased to announce data from a preclinical model demonstrating... June 12, 2018